Literature DB >> 4602026

Studies on 4-allyloxy-3 chlorophenylacetic acid (Alcofenac). A double-blind comparison of Alcofenac and aspirin in rheumatoid arthritis, and effects of therapy on serum immunoglobulins and rheumatoid factor.

M Aylward, R J Parker, J Maddock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4602026      PMCID: PMC1006254          DOI: 10.1136/ard.33.3.268

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  11 in total

1.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

2.  A double-blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders.

Authors:  M Anylward; D B Davies
Journal:  Br J Clin Pract       Date:  1972-11

3.  Alclofenac in rheumatoid arthritis: an evaluation of its anti-inflammatory and analgesic effects.

Authors:  M Aylward
Journal:  Br J Clin Pract       Date:  1973-07

4.  Double-blind comparison of alclofenac and phenylbutazone in the short-term treatment of rheumatoid arthritis.

Authors:  K Pavelka; O Vojtísek; A Brémova; D Kanková; D Handlová
Journal:  Curr Med Res Opin       Date:  1973       Impact factor: 2.580

5.  Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor.

Authors:  R Bluestone; L S Goldberg
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

6.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

7.  Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

Authors:  P L Boardman; F D Hart
Journal:  Br Med J       Date:  1967-11-04

8.  4-Allyloxy-3-chlorophenylacetic acid, a new type of analgesic, antipyretic and antiphlogistic drug.

Authors:  N P Buu-Hoï; G Lambelin; C Gillet; J Roba; M Staquet
Journal:  Naturwissenschaften       Date:  1969-06

9.  Pharmacology of a new analgesic, antipyretic, and anti-inflammatory agent, 4-allyloxy-3-chlorophenylacetic acid.

Authors:  G Lambelin; J Roba; C Gillet; N P Buu-Hoï
Journal:  Arzneimittelforschung       Date:  1970-05

10.  Toxicity studies of 4-allyloxy-3-chlorophenylacetic acid, a new analgesic, antipyretic, and anti-inflammatory agent.

Authors:  G Lambelin; J Roba; C Gillet; M Gautier; N P Buu-Hoï
Journal:  Arzneimittelforschung       Date:  1970-05
View more
  3 in total

1.  Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

2.  Alclofenac and D-penicillamine. Comparative trial in rheumatoid arthritis.

Authors:  H Berry; L Fernandes; A W Ford-Hutchinson; S J Evans; E B Hamilton
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

3.  Nonsteroidal acidic anti-inflammatory agents: do they constitute a single drug class?

Authors:  D C Atkinson
Journal:  Agents Actions       Date:  1979-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.